HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paradoxical anti-leukemic effects of plant-derived tumor promoters on a human thymic lymphoblast cell line.

Abstract
Three different diterpen polyols and the teleocidin have antileukemic effects on the human thymic leukemia cell line HPB-ALL by inducing phenotypic differentiation. We tested TPA (phorbol esters), mezerein (daphnane), milliamin (ingenol ester) and teleocidin B (teleocidins) as representative of the chemical structure of each principle and found that these agents have the similar biological activity of inducing phenotypic differentiation in HPB-ALL cells. Moreover, competitive binding of [3H]PDB to cell-surface receptors was significantly inhibited by these agents; n-butyrate and phorbol per se did not inhibit the binding of [3H]PDB. Despite differences in the structure of the principles, these agents may have similarly acting side-chain structures.
AuthorsY Nakao, S Matsuda, H Kimoto, T Matsui, N Kobayashi, M Kishihara, T Fujita, S Watanabe, K Ueda, Y Ito
JournalInternational journal of cancer (Int J Cancer) Vol. 30 Issue 6 Pg. 687-95 (Dec 15 1982) ISSN: 0020-7136 [Print] United States
PMID6819241 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Alkaloids
  • Antigens, Surface
  • Carcinogens
  • Diterpenes
  • Lyngbya Toxins
  • Phorbol Esters
  • Terpenes
  • Poly Adenosine Diphosphate Ribose
  • teleocidins
  • mezerein
  • Phorbol 12,13-Dibutyrate
  • DNA
Topics
  • Alkaloids (pharmacology)
  • Antigens, Surface (analysis)
  • Carcinogens (pharmacology)
  • Cell Differentiation (drug effects)
  • Cell Division (drug effects)
  • Cell Line
  • DNA (biosynthesis)
  • Diterpenes (pharmacology)
  • Fluorescent Antibody Technique
  • Humans
  • Leukemia, Lymphoid (metabolism, pathology)
  • Lyngbya Toxins
  • Phorbol 12,13-Dibutyrate
  • Phorbol Esters (metabolism, pharmacology)
  • Poly Adenosine Diphosphate Ribose (metabolism)
  • Rosette Formation
  • T-Lymphocytes
  • Terpenes

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: